Lord, Abbett & Co’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,168,376
Closed -$10.6M 709
2021
Q4
$10.6M Buy
1,168,376
+7,400
+0.6% +$68.8K 0.02% 478
2021
Q3
$11.7M Sell
1,160,976
-71,300
-6% -$782K 0.03% 503
2021
Q2
$15.8M Buy
1,232,276
+235,200
+24% +$3.23M 0.04% 458
2021
Q1
$14.1M Buy
997,076
+741,392
+290% +$10.2M 0.04% 468
2020
Q4
$2.73M Buy
255,684
+114,400
+81% +$1.04M 0.01% 620
2020
Q3
$1.08M Buy
+141,284
New +$1.04M ﹤0.01% 619

Other funds holding DBD

Lord, Abbett & Co's DBD Position: Q1 2022 in Review

Lord, Abbett & Co sold out of Diebold Nixdorf Incorporated (DBD) in Q1 2022, closing a stake of 1,168,376 shares — an estimated $10.6M sold.

Lord, Abbett & Co first reported a position in DBD in Q3 2020 and held it in 6 quarters. The position peaked at $15.8M in Q2 2021. 184 funds tracked by Wall St. Rank hold DBD as of Q1 2022.

  • Lord, Abbett & Co reported no remaining Diebold Nixdorf Incorporated position as of Q1 2022 after selling out during the quarter.
  • Lord, Abbett & Co sold 1,168,376 Diebold Nixdorf Incorporated shares in Q1 2022, an estimated $10.6M.
  • Lord, Abbett & Co first reported a position in Diebold Nixdorf Incorporated in Q3 2020 and held it in 6 quarters.
  • Lord, Abbett & Co's Diebold Nixdorf Incorporated position peaked at $15.8M in Q2 2021.
  • 184 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q1 2022.

Based on Lord, Abbett & Co's 13F filing for Q1 2022, filed 13 May 2022.